Sentences with phrase «over full cycle»

A 60 year cycle will not raise temperatures over a full cycle.

As shown in the previous table, markets do not always provide a satisfactory return over a full cycle.

I don't particularly like these business models, as they tend to produce mediocre returns on capital over the full cycle, but occasionally they do offer opportunities to buy them well below their net asset values.

Though many managers will say that the benchmark reflects their circle of competence, and they do well within those bounds, my view is that it is better to loosen the constraints on managers with good investment processes, and simply tell them that you are looking for good returns over a full cycle.

Echoing her suggestion, fund managers also often ask to be judged «over full cycle» when comparing performance against their peers.

The rankings are based on risk adjusted return, specifically Martin ratio, over each full cycle.

I continue to act as a nervous bull in this environment, making money where I can, and realizing that over a full cycle, my risk control disciplines will protect me in relative, but not absolute terms.

The Balanced Asset Class Index which included large caps, small caps, value stocks and bonds fared much better than the all - stock options and outperformed the other options over the full cycle 4 out of 5 times.

Over the full cycle, the market recognizes reasonably - valued stocks that throw off a reliable stream of cash to shareholders (especially those that exhibit enough investor sponsorship so that future cash flows aren't called into question on the basis of others» information).

The only true test of a money manager's ability is if he can obtain above - average results over a full cycle that includes both bull and bear markets.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

We'll confidently pursue our investment discipline in any event, in the full expectation that far better conditions will emerge to embrace market exposure over the completion of this cycle, as they always have in market cycles across history.

Strategic Growth is a risk - managed growth fund that is intended to accept exposure to U.S. stocks over the full market cycle, but with smaller periodic losses than a passive buy - and - hold approach.

If current levels were to turn out, in hindsight, to be the final lows of this decline, I suspect that the overall return over the next cycle (by the time we do observe a full 20 % loss) will be as tame as we've seen since the bull market started in 2003.

Historically - reliable valuation measures are remarkably useful in projecting long - term and full - cycle market outcomes, but the behavior of the market over shorter segments of the market cycle is driven by the psychological inclination of investors toward speculation or risk - aversion.

The only alternative to this view is to imagine that the collapses that followed valuation extremes like 1929, 1973, 2000, and 2007 somehow emerged entirely out of the blue, ignoring the fact that valuations accurately projected likely full - cycle losses, and remained tightly correlated with total returns over the subsequent 10 - 12 year horizons.

But understand that even when valuations don't «work» over shorter segments of the market cycle, the longer - term and full - cycle outcomes of hypervaluation are predictably brutal.

Over the long - term, we expect our relative performance to be an increment over-and-above the absolute performance of the markets we invest in (though this is certainly not true over periods shorter than a full market cycOver the long - term, we expect our relative performance to be an increment over-and-above the absolute performance of the markets we invest in (though this is certainly not true over periods shorter than a full market cycover-and-above the absolute performance of the markets we invest in (though this is certainly not true over periods shorter than a full market cycover periods shorter than a full market cycle).

If you combine the two, it happens that the average full market cycle is 5 years in duration, and generates an average total return of about 10.9 % over the entire cycle.

While that's not generally true over the short - term for investment management, it still tends to be true over the full market cycle.

At MFS ®, we believe a flexible, adaptable approach that includes exposure to a wide range of bond sectors is one key to generating attractive risk - adjusted returns and managing risk over full market cycles.

While past returns do not ensure future results, our objective is to substantially outperform a buy - and - hold approach over the full market cycle, with smaller periodic losses, on average.

SYG is an active fund that uses fundamental and quantitative models to screen for growth - oriented stocks, with the aim of beating the Russell 1000 Growth Index over a full market cycle.

While long - term and full - cycle market outcomes are tightly determined by market valuations, the effect of valuations on outcomes over shorter segments of the market cycle depends on the psychological preference of investors toward speculation or risk aversion.

We don't know whether the current instance will have consequences similar to the 1929, 1972, 1987, 2000 and 2007 ones, but suffice it to say that these conditions were more notable for their outcomes over the completion of the full market cycle than they were for their immediate outcomes.

However, over a full market cycle, each of the factors mentioned above has proven to be additive to portfolio returns.

While most active managers will state that their objective is to outperform over a full market cycle, they need to be more emphatic with asset owners up front about how much time that really entails and why they need it, especially if they state they have a long - term philosophy.

If a portfolio loads market risk when the likely return / risk profile is favorable, and hedges market risk when the likely return / risk profile is unfavorable, it's possible to achieve a very satisfactory return / risk profile over the full market cycle without ever making a specific short - term forecast.

Getting out of this trap starts with the clarity I've outlined — clarity around full market cycles, around investor time tolerance and around the need to evaluate performance over longer time periods.

The Fund will attempt to produce a total return in excess of the return of the S&P 500 Index, and secondarily, the Russell 1000 Value Index over a full market cycle.

The central message of our discipline is that valuations are enormously informative about prospects for long - term and full - cycle returns, but that outcomes over shorter segments of the market cycle are driven by changes in the psychological preferences of investors toward speculation or risk - aversion.

Full aneuploidy is unusual under age 30, but afflicts a third of cycles over age 40.

This occurs successively over multiple electoral cycles until all diversity and subtlety of opinion collapses into two parties - each full of sweeping useless generalisations and ideological cant.

This time frame allowed us to observe over almost a full seasonal cycle: we watched Saturn's and Titan's southern hemispheres go from summer to winter and their northern hemispheres go from winter to summer.

We recently extended this record to approximately 120,000 years BP in order to track vegetation change over a full glacial cycle at millennial to orbital timescales.

Over the years, yoga has taught me that I'm unequivocally responsible for taking care of my physical and mental health because if I don't take full responsibility for my behavior, I'll continue to wander around in a state of pain and anger and contribute to the very cycle I'm trying to break.

One of the film's so - called cute moments comes when Adam brings over cupcakes to Emma and her roomies, who are all on the same menstrual cycle, along with a «Period Mix», a CD full of songs like «Red Red Wine» and «Sunday Bloody Sunday».

A lack of focus on the marginalized has left the poorest five times less likely to complete a full cycle of primary education than the richest and over a third of out of school children living in conflict affected zones.

Classroom projects and lesson plans can be developed over a three - to six - week cycle or in one full - day session.

On a full charge, the battery is claimed to provide the e-tron quattro concept with a range of over 311 miles based on the criteria used in the New European Driving Cycle (NEDC) test procedure.

The real test of the Equinox will be how it drives and feels over a full test cycle.

The project aims to deliver full hybrid equivalent fuel economy and performance with less than 70 g / km CO2 emissions as measured over the European Drive Cycle, but at a significantly lower cost.

Spending $ 35,000 on a 2017 Honda Pilot, for example, will likely cost you measurably less over a full buy - own - sell ownership cycle than if you'd spent $ 35,000 on most any of its competitors.

Unusually, Kobo gives you full control over the refresh cycle.

The difference between a charge card and a credit card is that while credit cards allow you to carry a balance and pay it over time, charge cards require full payment at the end of every billing cycle once a statement has been issued.

For those casting about for tummy - calming options, we screened for funds that had been around for a full market cycle, then looked at funds which have the shortest recovery times and, separately, the lowest Ulcer Indexes over the current market cycle.

Driehaus Turnaround Opportunities Fund will seek to maximize capital appreciation, while minimizing the risk of permanent capital impairment, over full - economic cycles..

Over the full market cycle, ARTQX modestly leads its peer group in performance (40 bps / year) with subdued volatility.

Their goal is «positive total returns over a full market cycle.»

Over the course of a full market cycle however, valuations are ultimately what matter.